Hypertrophic cardiomyopathy (HCM) is a genetic
cardiovascular disease that predisposes individuals to the development of
arrhythmias. The most common sustained arrhythmia is atrial fibrillation (AF).
Compared with the general population, patients with HCM are more prone to the development
of AF. To avoid embolic complications and the clinical deteoriation caused by the
development of AF in HCM, identifying patients with a tendency toward AF might
affect the management of HCM. In this review, we evaluated the predictors of AF
development in patients with HCM.
Credits: Kamil Tuluce; Selcen Yakar Tuluce